Reach the investors backing rounds like this
Backed by Ottobock · verified emails and LinkedIn on Datapile
Ottobock stock backs Blue Arbor's 10.5 million US-dollar round - ad-hoc-news.de
Blue Arbor Technologies is developing the RESTORE Neuromuscular Interface System, designed for independent and simultaneous control of prosthetic limbs. The company is advancing both external and implantable versions of its sensing interface. This funding will support feasibility studies and regulatory efforts for clinical trials.
Ottobock stock backs Blue Arbor's 10.5 million US-dollar round ad-hoc-news.de
| Oct 29, 2026 | Jagruti Rehabilitation Centre | $3.4M | Series A | — |
| Oct 29, 2026 | Docterz | $620K | — | India |
| Oct 29, 2026 | StimCardio | $30.0M | Series A | United States |
| Oct 28, 2026 | NeuroXess | $96.6M | Series B | China |
You just read who funded Blue Arbor Technologies. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.